Internal Medicine, Endocrinology, Diabetes, & Metabolism · Conyers, GA
NPI
1538588249
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1301 Sigman Rd NE Ste 280
Conyers, GA, 30012
Phone (678) 413-6276
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
1,116 services
Medicare patients, 2024
209
Average age 72
Drug cost, 2024
$3.2M
5,195 prescriptions
Company payments, 2025
$419
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wedad Rahman was code 99214 (office e&m - established), 312 times for 164 patients. In total Wedad Rahman billed 1,116 services in 10 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 312 | 164 | $93.54 | $29K |
| 82962 Clinical Chemistry | Office | 248 | 117 | $3.20 | $793 |
| 83036 Blood Count | Office | 185 | 98 | $9.47 | $1,752 |
| 95251 Test - Miscellaneous | Office | 133 | 60 | $26.92 | $3,581 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 122 | 81 | $11.65 | $1,422 |
| 99215 Office E&M - Established | Office | 53 | 39 | $128.73 | $6,823 |
| 99204 Office E&M - New | Office | 47 | 47 | $115.88 | $5,447 |
| 99205 Office E&M - New | Office | 13 | 13 | $164.69 | $2,141 |
By year: 2022 $49K for 972 services; 2023 $32K for 651 services; 2024 $51K for 1,116 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 248 | 117 | $3.20 | $793 |
| 83036 Blood Count | 185 | 98 | $9.47 | $1,752 |
Medicare prescription drug claims, 2024
In 2024, the drug Wedad Rahman prescribed most often to Medicare patients was Ozempic (Semaglutide), with 366 prescriptions and refills. In total Wedad Rahman wrote 5,195 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 366 | 712 | 96 | $700K |
| Levothyroxine Sodium Generic | 364 | 946 | 107 | $3,751 |
| Trulicity Dulaglutide | 315 | 535 | 95 | $519K |
| Metformin Hcl Generic | 314 | 892 | 115 | $1,715 |
| Glipizide Er Glipizide | 288 | 813 | 93 | $3,024 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 259 | 582 | 101 | $29K |
| Jardiance Empagliflozin | 251 | 510 | 69 | $291K |
| Novolog Flexpen Insulin Aspart | 204 | 469 | 85 | $73K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 180 | 489 | 77 | $29K |
| Gvoke Hypopen 2-Pack Glucagon | 173 | 184 | 107 | $116K |
| Methimazole Generic | 158 | 410 | 43 | $943 |
| Tresiba Flextouch U-100 Insulin Degludec | 110 | 242 | 46 | $69K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 108 | 212 | 38 | $45K |
| Metformin Hcl Er Metformin Hcl | 98 | 266 | 36 | $689 |
| Tresiba Flextouch U-200 Insulin Degludec | 93 | 243 | 38 | $141K |
Brand drugs: 2,902 claims; generic drugs: 1,540 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wedad Rahman $419 ($419 in general payments such as food, travel and fees) from 11 companies. The largest payer was Sanofi-Aventis U.S. LLC with $75.54.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 3 | $75.54 |
| Novo Nordisk Inc NVO | 2 | $54.44 |
| Radius Health, Inc. | 2 | $54.2 |
| Beta Bionics, Inc. BBNX | 2 | $52.71 |
| Lilly USA, LLC LLY | 2 | $48.51 |
| Abbvie Inc. ABBV | 2 | $36.21 |
| Xeris Pharmaceuticals, Inc. | 1 | $24.44 |
| Amphastar Pharmaceuticals, Inc. AMPH | 1 | $21.89 |
| Recordati_rare_diseases_inc. | 1 | $18.5 |
| Corcept Therapeutics CORT | 1 | $17.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.